TrialCancer medicine2023

A nomogram model for predicting the risk of checkpoint inhibitor-related pneumonitis for patients with advanced non-small-cell lung cancer.

Yao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.